Singapore, Republic of Singapore
- CME:
- 11 ESMO-MORA category 1 points
- Application deadline:
- Closed
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
ESMO Preceptorships focus on a specific malignancy or oncology topic and aim to provide oncologists with a thorough understanding of the management of the disease from diagnosis to treatment, according to current standards of care, with a particular focus on medical oncology in a multidisciplinary setting.
These courses are designed primarily for medical and clinical oncologists, and they are particularly suitable for young oncologists and for general oncologists wishing to update their knowledge.
Comprising plenary lectures by a multidisciplinary faculty of international experts and case-based sessions, ESMO Preceptorship courses offer an enriched learning experience, thanks to their small size and emphasis on interaction with fellow participants and faculty.
Courses are open to ESMO members, and travel grants are offered to selected participants.
ESMO Preceptorships are typically 1.5 days in duration and accredited with ESMO-MORA category 1 points.
Singapore, Republic of Singapore
Singapore, Republic of Singapore
Singapore, Republic of Singapore
Lugano, Switzerland
Cape Town, South Africa
Lugano, Switzerland
Manchester, United Kingdom
Zurich, Switzerland
Lima, Peru
Lima, Peru
Lugano, Switzerland
Valencia, Spain
Lugano, Switzerland
Munich, Germany
Madrid, Spain
Barcelona, Spain
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.